Khosrovi Behzad 4/A
4/A · NovaBay Pharmaceuticals, Inc. · Filed Dec 22, 2010
Insider Transaction Report
Form 4/AAmended
Khosrovi Behzad
VP Research and Development
Transactions
- Award
Option (right to buy)
2010-11-15+40,000→ 364,200 totalExercise: $1.89From: 2011-11-15Exp: 2020-11-14→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]Original Form 4 filed on Nobember 15, 2010. This amendment is filed to correct the exercise price from $1.85 to 1.885 per share.
- [F2]Original Form 4 filed on November 15, 2010. This amendment is filed to correct the grant date from November 12, 2010 to November 15, 2010, the date the last signature to the Board Written Consent granting the options was received by the Company.